These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 16041534)

  • 41. Protective effect of rivastigmine against 3-nitropropionic acid-induced Huntington's disease like symptoms: possible behavioural, biochemical and cellular alterations.
    Kumar P; Kumar A
    Eur J Pharmacol; 2009 Aug; 615(1-3):91-101. PubMed ID: 19445928
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of hydrocortisone administration on cognitive function in the elderly.
    Porter RJ; Barnett NA; Idey A; McGuckin EA; O'Brien JT
    J Psychopharmacol; 2002 Mar; 16(1):65-71. PubMed ID: 11949774
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Rivastigmine reverses aluminum-induced behavioral changes in rats.
    Abdel-Aal RA; Assi AA; Kostandy BB
    Eur J Pharmacol; 2011 Jun; 659(2-3):169-76. PubMed ID: 21440537
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cholinesterase inhibitors, donepezil and rivastigmine, attenuate spatial memory and cognitive flexibility impairment induced by acute ethanol in the Barnes maze task in rats.
    Gawel K; Labuz K; Gibula-Bruzda E; Jenda M; Marszalek-Grabska M; Filarowska J; Silberring J; Kotlinska JH
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Oct; 389(10):1059-71. PubMed ID: 27376896
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Methylthioninium chloride reverses cognitive deficits induced by scopolamine: comparison with rivastigmine.
    Deiana S; Harrington CR; Wischik CM; Riedel G
    Psychopharmacology (Berl); 2009 Jan; 202(1-3):53-65. PubMed ID: 19005644
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The effects of rivastigmine on processing speed and brain activation in patients with multiple sclerosis and subjective cognitive fatigue.
    Huolman S; Hämäläinen P; Vorobyev V; Ruutiainen J; Parkkola R; Laine T; Hämäläinen H
    Mult Scler; 2011 Nov; 17(11):1351-61. PubMed ID: 21846692
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dopamine-antagonistic, anticholinergic, and GABAergic effects on declarative and procedural memory functions.
    Rammsayer TH; Rodewald S; Groh D
    Brain Res Cogn Brain Res; 2000 Jan; 9(1):61-71. PubMed ID: 10666558
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Rivastigmine and donepezil treatment in moderate to moderately-severe Alzheimer's disease over a 2-year period.
    Bullock R; Touchon J; Bergman H; Gambina G; He Y; Rapatz G; Nagel J; Lane R
    Curr Med Res Opin; 2005 Aug; 21(8):1317-27. PubMed ID: 16083542
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cognitive function in early clinical phase huntington disease after rivastigmine treatment.
    Sešok S; Bolle N; Kobal J; Bucik V; Vodušek DB
    Psychiatr Danub; 2014 Sep; 26(3):239-48. PubMed ID: 25191771
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of anticholinergic challenge on psychopathology and cognition in drug-free patients with schizophrenia and healthy volunteers.
    Veselinović T; Vernaleken I; Janouschek H; Kellermann T; Paulzen M; Cumming P; Gründer G
    Psychopharmacology (Berl); 2015 May; 232(9):1607-17. PubMed ID: 25373869
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Histamine H1-receptor blockade in humans affects psychomotor performance but not memory.
    van Ruitenbeek P; Vermeeren A; Riedel W
    J Psychopharmacol; 2008 Aug; 22(6):663-72. PubMed ID: 18208925
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Performance of conventional pigs and Göttingen miniature pigs in a spatial holeboard task: effects of the putative muscarinic cognition impairer Biperiden.
    Gieling E; Wehkamp W; Willigenburg R; Nordquist RE; Ganderup NC; van der Staay FJ
    Behav Brain Funct; 2013 Jan; 9():4. PubMed ID: 23305134
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An extract of Salvia (sage) with anticholinesterase properties improves memory and attention in healthy older volunteers.
    Scholey AB; Tildesley NT; Ballard CG; Wesnes KA; Tasker A; Perry EK; Kennedy DO
    Psychopharmacology (Berl); 2008 May; 198(1):127-39. PubMed ID: 18350281
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Rivastigmine for HIV-associated neurocognitive disorders: a randomized crossover pilot study.
    Simioni S; Cavassini M; Annoni JM; Métral M; Iglesias K; Rimbault Abraham A; Jilek S; Calmy A; Müller H; Fayet-Mello A; Giacobini E; Hirschel B; Du Pasquier RA
    Neurology; 2013 Feb; 80(6):553-60. PubMed ID: 23345635
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of a diet integration with an oily emulsion of DHA-phospholipids containing melatonin and tryptophan in elderly patients suffering from mild cognitive impairment.
    Rondanelli M; Opizzi A; Faliva M; Mozzoni M; Antoniello N; Cazzola R; Savarè R; Cerutti R; Grossi E; Cestaro B
    Nutr Neurosci; 2012 Mar; 15(2):46-54. PubMed ID: 22334085
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of rivastigmine on visual attention in subjects with amnestic mild cognitive impairment: A serial functional MRI activation pilot-study.
    Bokde AL; Cavedo E; Lopez-Bayo P; Lista S; Meindl T; Born C; Galluzzi S; Faltraco F; Dubois B; Teipel SJ; Reiser M; Möller HJ; Hampel H
    Psychiatry Res Neuroimaging; 2016 Mar; 249():84-90. PubMed ID: 26851974
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Delay-dependent cholinergic modulation of visual short-term memory in rhesus macaques.
    Knakker B; Oláh V; Trunk A; Lendvai B; Lévay G; Hernádi I
    Behav Brain Res; 2021 Jan; 396():112897. PubMed ID: 32891649
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx study.
    Feldman HH; Ferris S; Winblad B; Sfikas N; Mancione L; He Y; Tekin S; Burns A; Cummings J; del Ser T; Inzitari D; Orgogozo JM; Sauer H; Scheltens P; Scarpini E; Herrmann N; Farlow M; Potkin S; Charles HC; Fox NC; Lane R
    Lancet Neurol; 2007 Jun; 6(6):501-12. PubMed ID: 17509485
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of rivastigmine on sustained attention in schizophrenia: an FMRI study.
    Aasen I; Kumari V; Sharma T
    J Clin Psychopharmacol; 2005 Aug; 25(4):311-7. PubMed ID: 16012272
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effects of rasagiline on cognitive deficits in Parkinson's disease patients without dementia: a randomized, double-blind, placebo-controlled, multicenter study.
    Hanagasi HA; Gurvit H; Unsalan P; Horozoglu H; Tuncer N; Feyzioglu A; Gunal DI; Yener GG; Cakmur R; Sahin HA; Emre M
    Mov Disord; 2011 Aug; 26(10):1851-8. PubMed ID: 21500280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.